This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (16) Citing Articles via Google Scholar Google Scholar Articles by Katz, N. P. Articles by Custer, L. M. Search for Related Content PubMed PubMed Citation Articles by Katz, N. P. Articles by Custer, L. M. Related Collections Equipment Pain Pharmacology

---

ANESTHETIC PHARMACOLOGY

Rapid Onset of Cutaneous Anesthesia with EMLA Cream After Pretreatment with a New Ultrasound-Emitting Device

From the Pain Trials Center, Brigham & Women’s Hospital, Boston, Massachusetts

Address correspondence and reprint requests to Joseph Kost, PhD, Chief Scientific Officer, Sontra Medical, 10 Forge Parkway, Franklin, MA 02038. Address email to jkost{at}sontra.com

In this randomized, double-blinded, placebo-controlled, crossover trial of 42 human subjects, we examined the speed of onset of cutaneous anesthesia by eutectic mixture of local anesthetics (EMLA) cream after brief (approximately 10-s) pretreatment of the underlying skin with low-frequency (55 kHz) ultrasound. Four treatments were compared: ultrasound pretreatment followed by application of 1 g EMLA or placebo cream for 5 min, 10 min, 15 min, and 60 min without ultrasound pretreatment as positive control. Pain was tested by pricks with a 20 g needle. Pain scores and patient preference for EMLA or placebo cream were measured at each time point. Based on both pain scores and patient preference, cutaneous anesthesia was achieved in the EMLA groups as compared with placebo at all time points. After ultrasound pretreatment and then 5, 10, or 15 min after EMLA cream application, pain scores and overall preference were statistically indistinguishable from EMLA cream application for 60 min (without ultrasound pretreatment). There were no significant adverse effects. Low-frequency ultrasound pretreatment appears to be safe and effective in producing rapid onset of EMLA cream in this model, with results as early as 5 min.

IMPLICATIONS: A prospective, randomized, double-blinded, placebo-controlled clinical trial demonstrated rapid onset of cutaneous anesthesia by pretreatment of the skin with ultrasound before application of EMLA cream.

This article has been cited by other articles:

				N. L. Schechter, W. T. Zempsky, L. L. Cohen, P. J. McGrath, C. M. McMurtry, and N. S. Bright Pain Reduction During Pediatric Immunizations: Evidence-Based Review and Recommendations Pediatrics, May 1, 2007; 119(5): e1184 - e1198. [Abstract] [Full Text] [PDF]

				D. A Calhoun, S N. Murthy, B. G Bryant, S. A Luedtke, and V. Bhatt-Mehta Recent Advances in Neonatal Pharmacotherapy Ann. Pharmacother., April 1, 2006; 40(4): 710 - 719. [Abstract] [Full Text] [PDF]